Skip to main content

Pharmacogenomics Technology Market Price (Revenue, USD Million; 2014 - 2025)

The pharmacogenomics theranostics market is segmented by application, technology, end-user, and geography. By application, the segmentation goes like cardiovascular disease, pain management, psychiatry, infectious diseases, oncology, and neurological disease. By technology, the pharmacogenomics technology industry spans sequencing, polymerase chain reaction, mass spectrometry, microarray, and electrophoresis. By end-user, the pharmacogenomics companion diagnostics (CDx) market states research organizations & academic institutes and hospitals and clinics. By geography, it comprises North America, Asia Pacific, LATAM, Europe, and MEA.

Download Free Sample  - https://www.millioninsights.com/industry-reports/pharmacogenomics-technology-market/request-sample

North America rules the roost; thanks to extensive investment in healthcare by the U.S. Europe comes in second due to Belgium and Denmark being on the top pedestal with respect to healthcare. Asia Pacific is expected to grow at the fastest pace owing to increase in awareness among the economies like India and China regarding healthcare. LATAM will also catch up due to presence of Brazil; followed by MEA. In fact, MEA would be more vigilant on this count; due to the figures released by WHO. It says that over 50% of the diseases mentioned above occur in sub-Saharan Africa.

Players:

The players contributing to the pharmacogenomics technology market include OPKO Health, Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceutical Industries Ltd., Dynamic DNA Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., One Ome LLC, Empire Genomics, LLC, and Illumina, Inc.

Comments

Popular posts from this blog

Global Real-time Rendering Solutions Market Analysis, Trends and Future Prospects, 2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Real-time Rendering Solutions Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). Download free PDF sample copy @  https://www.radiantinsights.com/research/global-real-time-rendering-solutions-market-research-report-2019-2023/request-sample In this report, the global Real-time Rendering Solutions market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023. The report firstly introduced the Real-time Rendering Solutions basics: definitions, classifications, applicatio...

What are the key end-use segments in the global Decoquinate-Based Products industry?

Decoquinate (ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate) is an antiprotozoal agent. It acts against coccidia parasites and is thus known as a coccidiostat. Decoquinate-based products are majorly used in veterinary medicine. The global decoquinate-based products market is segmented based on the type of formulation, and geography.  Decoquinate acts on the sporozoite stage of a coccidian parasite’s lifecycle. The sporozoite can penetrate the host’s intestinal call and prevents their further development, which necessitates the use of antiprotozoal substances. Decoquinate has low toxicity and is administered orally to a wide range of mammalian and avian species. Various studies conducted on decoquinate-based products suggest that the drug is readily tolerated by several target species including cattle and lambs. On the other hand, studies conducted on rats and dogs showed minor changes in food consumption, feed conversion, subdued behavior, and changes in body weight and o...

United States Kombucha Market Trends, Share & Scope, Product Estimates & Strategy Framework To 2019-2023: Radiant Insights, Inc

In this report, the United States Kombucha market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Download free sample @  https://www.radiantinsights.com/research/united-states-kombucha-industry-2017/request-sample Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Kombucha in these regions, from 2012 to 2022 (forecast). United States Kombucha market competition by top manufacturers/players, with Kombucha sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including GT's Kombucha KeVita Brew Dr. Kombucha The Humm Kombucha Live Soda Kombucha Red Bull Kombucha Wonder Drink Townshend's Tea Celestial Seasonings Kosmic Kombuc...